How big is the Huntington's Disease Treatment Market?

The Huntington's Disease Treatment Market size is expected to reach USD 0.76 billion in 2024 and grow at a CAGR of 8.23% to reach USD 1.35 billion by 2029. Read More

What is the current Huntington's Disease Treatment Market size?

In 2024, the Huntington's Disease Treatment Market size is expected to reach USD 0.76 billion. Read More

Who are the key players in Huntington's Disease Treatment Market?

Pfizer, Inc., Alnylam Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Neurocrine Biosciences, Inc. and Ionis Pharmaceuticals are the major companies operating in the Huntington's Disease Treatment Market. Read More

Which is the fastest growing region in Huntington's Disease Treatment Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Huntington's Disease Treatment Market?

In 2024, the North America accounts for the largest market share in Huntington's Disease Treatment Market. Read More

What years does this Huntington's Disease Treatment Market cover, and what was the market size in 2023?

In 2023, the Huntington's Disease Treatment Market size was estimated at USD 0.70 billion. The report covers the Huntington's Disease Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Huntington's Disease Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Huntington's Disease Treatment Market Share

Statistics for the 2023 & 2024 Huntington's Disease Treatment market share, created by Mordor Intelligence™ Industry Reports. Huntington's Disease Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Huntington's Disease Treatment Industry

The Huntington's disease treatment market is competitive with several large, small, and medium-sized players. Some of the companies dominating the market are Pfizer Inc., Alnylam Pharmaceuticals Inc., Ceregene Inc., Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd, Ionis Pharmaceuticals, Neurocrine Biosciences Inc., Prilenia Therapeutics, Azevan Pharmaceuticals, and Lundbeck.